Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Female × Dexmedetomidine × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Pain, Postoperative 3 Sleep Initiation and Maintenance Disorders 1 Pain 1 Female Patients Under the Age of 65 Who Will Undergo Breast Cancer Surgery 1 Chronic Pain 1 Breast Cancer Patients 1 Breast Cancer Female 1

Interventions

Tamoxifen 4 Exercise 3 pyrotinib 2 abemaciclib 2 Paclitaxel 2 Metformin 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 Aromatase Inhibitors 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tumor Burden 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03063073 2026-02-12

pec's

South Egypt Cancer Institute

Phase 3 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡